Drug Watch

Sports Psychiatry

Digital Therapeutics

Postpartum Depression

Diversity, Equity, Inclusion

Mental Health Awareness Month

Ethics

Cannabis

Climate Change

Psychedelics

Transcranial Magnetic Stimulation

Media & Psychiatry

COVID-19

Disaster Psychiatry

Panic Disorder

Trauma And Violence

Traumatic Stress Disorders

Anxiety & Stress Disorders

Comorbidity

Cultural Psychiatry

Alzheimer Disease

Eating Disorders

Munchausen Syndrome

Sexual Offenses

Forensic Psychiatry

Geriatric Psychiatry

Integrative Psychiatry

Major Depressive Disorder

Mood Disorders

Gambling

Opioid Related Disorders

Alcohol Abuse

Amphetamine Related Disorders

Substance Use Disorder

Addiction & Substance Use

Compulsive Disorders

Compulsive Personality Disorder

Dependent Personality Disorder

Dissociative Identity Disorder

Histrionic Personality Disorder

Schizoid Personality Disorder

Antisocial Personality Disorder

Borderline Personality

Personality Disorders

Emergency Psychiatry

Psychopharmacology

Cognitive Behavioral Therapy

Psychotherapy

PTSD

Delirium

Metabolic Disorders

Somatoform Disorder

Psychosomatics

Cognitive Disorders

Dementia

Autism

Neuropsychiatry

Paranoid Schizophrenia

Psychotic Affective Disorders

Schizoaffective

Schizophrenia Psychotic Features

Schizotypal Personality Disorder

Catatonic Schizophrenia

Schizophrenia/Psychosis

Suicide

Technology & Psychiatry

Tardive Dyskinesia

Mania

Bipolar Disorder

Pervasive Developmental Disorder

Gender Issues

Military Mental Health

Special Populations

Nocturnal Paroxysmal Dystonia

Sleep Deprivation

Sleep Wake Transition

Circadian Rhythm Sleep Disorders

Sleep Disorders

Case Discussions

Child & Adolescent Psychiatry

ADHD

News

Media

Peer Exchange

Case-Based Psych Perspectives

Clinical Case Collective

Insights

Peers & Perspectives

Slideshows

Videos

Conferences

Conference Coverage

Conference Listing

Publication

Psychiatric Times

Job Board

CME/CE

Partners

Editorial

Resources

Between the Lines

Expert Perspectives

Clinical Consult

Clinical Scales

Interactive Tools

Partner Perspectives

Quizzes

Series

Special Reports

Subscribe

Articles

Alto Neuroscience's ALTO-203 trial reveals mixed results, highlighting potential biomarkers for targeted depression treatment despite missing primary efficacy goals.

ALTO-203 Fails to Primary Efficacy Endpoint in Phase 2 Major Depressive Disorder Trial

is an award-winning psychiatrist who specialized in the cultural and ethical aspects of psychiatry and is now in retirement and retirement as a private pro bono community psychiatrist. A prolific writer and speaker, he has done a weekday column titled “Psychiatric Views on the Daily News” and a weekly video, “Psychiatry & Society,” since the COVID-19 pandemic emerged. He was chosen to receive the 2024 Abraham Halpern Humanitarian Award from the American Association for Social Psychiatry. Previously, he received the Administrative Award in 2016 from the American Psychiatric Association, the one-time designation of being a Hero of Public Psychiatry from the Speaker of the Assembly of the APA in 2002, and the Exemplary Psychiatrist Award from the National Alliance for the Mentally Ill in 1991. He presented the third Rabbi Jeffrey B. Stiffman lecture at Congregation Shaare Emeth in St. Louis on Sunday, May 19, 2024. He is an advocate and activist for mental health issues related to climate instability, physician burnout, and xenophobia. He is now editing the final book in a 4-volume series on religions and psychiatry for Springer: Islamophobia, anti-Semitism, Christianity, and now

 The Eastern Religions, and Spirituality

Explore the intriguing connections between afterlife beliefs, personal experiences, and the psychological impact of grief in this thought-provoking analysis.

The Afterlife and Psychiatry

Researchers uncover a novel biomarker for major depressive disorder, linking regional homogeneity in fMRI to decreased cerebral blood flow and symptom severity.

Functional vs Structural Cortical Deficit Pattern Biomarkers for Major Depressive Disorder

Augmented reality can transform psychiatric treatment, enhancing exposure therapy for trauma and anxiety by simulating real-world environments and interactions.

AI and Augmented Reality: A Transdiagnostic Tool for Real-World Function

Psychiatric Times is the connection to Psychiatry and Mental Health, featuring clinical updates, expert views, and research news in multimedia formats.

About

Advertise

Contact Us

Terms and Conditions

Privacy Policy

Do Not Sell My Personal Information

Psychiatric Times - Mental Health News, Clinical Insights

Facebook

LinkedIn

Spotlight

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia

Preparing redirect...